May 8 (Reuters) - Valeant Pharmaceuticals International Inc reported first-quarter loss compared with a year-ago profit and said on Tuesday it would change its name to Bausch Health Companies Inc.
Net loss attributable to the company was at $2.69 billion, or $7.68 per share, in the quarter ended March 31, compared with a profit of $628 million, or $1.79 per share, a year earlier.
Total revenues fell 5.4 percent to $1.96 billion.
Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur
Our Standards: The Thomson Reuters Trust Principles.